On April 21st, 2021, Huayi organized an event in which more than 200 representatives from nationwide pharmaceutical enterprises visited the factory. Around the theme of “How the Chinese MA holders keep in line with Requirements in European and American markets”, they exchanged ideas about a parallel product registration in both China and Europe and differences between China and Europe in quality management and technical transfer.
Mr. Gao Yu, Chairman of Huayi, first extended a warm welcome to all the guests. Then Mr. Zhou Chaoxun, Commercial Director of Huayi, gave a brief introduction of the company. Huayi is a professional CDMO with 15 years of experience in oral preparations for Chinese, EU and UK customers. It built up an integrative service platform including R&D, clinical study, biological sample testing and commercial production.
The directors of individual business fields of Huayi also introduced their work scope to the guests.
Mr. Cao Cheng, R&D Director of Huayi, shared his insight into the key points at the stages of project selection, product development and MA application. Mrs. Huang Xiaofeng, Vice General Manager of Huayi, discussed the differences of quality management requirements between China and EU. Huayi’s technical process engineer Mr. Wan Shan gave some professional advices on how a product can be smoothly scaled up into commercial manufacturing via case analysis.
This event received positive feedback from the guests and stepped up the technical exchange between Huayi and other pharmaceutical enterprises. Huayi looks forward to working with more pharmaceutical enterprises in China and worldwide.